# Cancer Peptide Vaccines Sector

Canonical URL: https://biopharmsignal.com/sector/cancer-peptide-vaccines

Cancer Peptide Vaccines includes companies developing peptide-based therapeutic vaccines for oncology. These programs are designed to train the immune system against tumor-associated or tumor-specific antigens and are often paired with broader immunotherapy strategies.

Companies currently grouped under Cancer Peptide Vaccines: 2

## Recent Sector News

- 2026-08-13 12:30 EST — PDSB — [PDS Biotech Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/PDSB/pds-biotech-reports-second-quarter-2026-financial-results-a0124437) — Source: PDS Biotechnology Corporation
- 2026-08-11 12:25 EST — PDSB — [PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101](https://biopharmsignal.com/news/PDSB/pds-biotech-announces-strategic-refocus-prioritizing-pds0301-in-metastatic-color-b990cc7f) — Source: PDS Biotechnology Corporation
- 2026-08-10 10:00 EST — GLSI — [Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-extends-lock-up-of-directors-and-officers-to-january-31-2-d5042182) — Source: Greenwich LifeSciences
- 2026-07-22 10:00 EST — GLSI — [Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-approval-to-expand-flamingo-01-into-the-united--ec05cb97) — Source: Greenwich LifeSciences
- 2026-07-20 10:00 EST — GLSI — [Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-clinical-updates-on-flamingo-01-99f074c4) — Source: Greenwich LifeSciences
- 2026-07-16 11:30 EST — GLSI — [Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-european-approval-for-combining-both-hla-popula-adf83f60) — Source: Greenwich LifeSciences
- 2026-07-09 10:00 EST — GLSI — [Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-european-approval-for-use-of-commercially-manuf-3adb0b48) — Source: Greenwich LifeSciences
- 2026-06-01 12:15 EST — GLSI — [Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-asco-meeting-2026) — Source: Greenwich LifeSciences
- 2026-06-01 10:00 EST — GLSI — [Greenwich LifeSciences Provides Update Regarding Form 10-K Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-regarding-form-10-k-filing-5fb4f975) — Source: Greenwich LifeSciences
- 2026-05-22 20:30 EST — GLSI — [Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-q-filing) — Source: Greenwich LifeSciences
- 2026-05-13 11:00 EST — PDSB — [PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update](https://biopharmsignal.com/news/PDSB/pds-biotech-reports-first-quarter-2026-financial-results-and-provides-clinical-p-0e7c9dd2) — Source: PDS Biotechnology Corporation
- 2026-05-06 12:00 EST — PDSB — [PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results](https://biopharmsignal.com/news/PDSB/pds-biotech-announces-conference-call-and-webcast-for-2026-first-quarter-financi-02129dba) — Source: PDS Biotechnology Corporation
- 2026-04-30 10:00 EST — GLSI — [Greenwich LifeSciences Provides Update Regarding Form 10-K Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-regarding-form-10-k-filing) — Source: Greenwich LifeSciences
- 2026-04-23 10:00 EST — GLSI — [Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-acceptance-of-abstract-at-asco-2026) — Source: Greenwich LifeSciences
- 2026-04-22 21:00 EST — GLSI — [Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing) — Source: Greenwich LifeSciences
- 2026-04-20 10:00 EST — GLSI — [Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-aacr-meeting-2026) — Source: Greenwich LifeSciences
- 2026-04-15 12:45 EST — PDSB — [PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial](https://biopharmsignal.com/news/PDSB/pds-biotech-announces-publication-of-positive-pds01adc-interim-phase-2-clinical--180f6097) — Source: PDS Biotechnology Corporation
- 2026-04-14 10:00 EST — GLSI — [Greenwich LifeSciences Provides Update on Financing Strategy](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-on-financing-strategy) — Source: Greenwich LifeSciences
- 2026-04-07 10:00 EST — GLSI — [Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-on-patent-claims-potentially-doubling-gp2-market-potential) — Source: Greenwich LifeSciences
- 2026-03-30 11:00 EST — PDSB — [PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement](https://biopharmsignal.com/news/PDSB/pds-biotech-reports-full-year-2025-financial-results-and-provides-update-on-pds0-393b6df6) — Source: PDS Biotechnology Corporation

## Companies

- [GLSI](https://biopharmsignal.com/company/GLSI) — Greenwich LifeSciences
- [PDSB](https://biopharmsignal.com/company/PDSB) — PDS Biotechnology Corporation